Basta Steven L 4
4 · Phathom Pharmaceuticals, Inc. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Basta Steven L
DirectorPresident and CEO
Transactions
- Award
Performance Shares
2025-04-03+360,000→ 360,000 total→ Common Stock (360,000 underlying) - Award
Stock Option (Right to Buy)
2025-04-03+1,085,000→ 1,085,000 totalExercise: $5.01Exp: 2035-04-02→ Common Stock (1,085,000 underlying)
Footnotes (3)
- [F1]Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The performance stock units will vest based on the achievement of stock price hurdles and service-based vesting requirements over a period of four years following the grant date.
- [F3]The stock option will vest with respect to 25% of the shares of common stock on April 3, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.